OREANDA-NEWS. The Board of Hygea vct plc announces that Hygea's largest investment by value, Scancell plc (www.scancell.co.uk), is presenting at the Biotech Capital Conference being held in London on 3rd March 2016. Attendance is free, with registration via www.biotech-capital.com/conferences - a recording of the event will be posted on the website. An article Immunotherapy: a turning point in cancer treatment  by Vadim Alexandre can be found on page 8 of the AIM Journal (http://www.hubinvest.com/AIMPDFFebruary2016_77.pdf).